Jens Lundgren

Jens Lundgren

Clinical Professor

Member of:

  • Internal medicine: infection medicine

ORCID: 0000-0001-8901-7850

Publication year:
All
11 - 20 out of 39Page size: 10
  1. 2022
  2. Published

    Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)

    Murray, D. D., Babiker, A. G., Baker, J. V., Barkauskas, C. E., Brown, S. M., Chang, C. C., Davey, V. J., Gelijns, A. C., Ginde, A. A., Grund, B., Higgs, E., Hudson, F., Kan, V. L., Lane, H. C., Murray, T. A., Paredes, R., Parmar, M. K. B., Pett, S., Phillips, A. N., Polizzotto, M. N. & 8 others, Reilly, C., Sandkovsky, U., Sharma, S., Teitelbaum, M., Thompson, B. T., Young, B. E., Neaton, J. D. & Lundgren, Jens, 2022, In: Clinical Trials. 19, 1, p. 52-61 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Development and Validation of a Risk Score for Post-Transplant Lymphoproliferative Disorders among Solid Organ Transplant Recipients

    Santos, Q. D., Wareham, N. E., Mocroft, A., Rasmussen, A., Gustafsson, Finn, Perch, Michael, Sørensen, Søren Schwartz, Manuel, O., Müller, N. J., Lundgren, Jens & Reekie, J., 2022, In: Cancers. 14, 13, 13 p., 3279.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Early Biomarker-Guided Prediction of Bloodstream Infection in Critically Ill Patients: C-Reactive Protein, Procalcitonin, and Leukocytes

    Hertz, Frederik Boëtius, Ahlström, M. G., Bestle, Morten Heiberg, Hein, L., Mohr, T., Lundgren, Jens, Galle, T., Andersen, M. H., Murray, D., Lindhardt, A., Itenov, Theis Skovsgaard & Jensen , Jens-Ulrik Stæhr , 2022, In: Open Forum Infectious Diseases. 9, 10, ofac467.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Early stimulated immune responses predict clinical disease severity in hospitalized COVID-19 patients

    Svanberg, R., MacPherson, C., Zucco, A., Agius, R., Faitova, T., Andersen, M. A., da Cunha-Bang, C., Gjærde, L. K., Møller, M. E. E., Brooks, P. T., Lindegaard, B., Sejdic, A., Harboe, Z. B., Gang, A. O., Hersby, D. S., Brieghel, C., Nielsen, S. D., Podlekareva, D., Hald, A., Bay, J. T. & 6 others, Marquart, Hanne Vibeke Hansen, Lundgren, Jens, Lebech, Anne-Mette, Helleberg, Marie, Niemann, Carsten & Ostrowski, Sisse Rye, 2022, In: Communications Medicine. 2, 15 p., 114.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19: A Randomized Controlled Trial

    ACTIV-3/TICO Study Group, A. S. G., 2022, In: Annals of Internal Medicine. 175, 9, p. 1266-1274 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Enabling timely HIV postexposure prophylaxis access in sub-Saharan Africa

    Phillips, A. N., Sibanda, E., Sikwese, K., Bansi-Matharu, L., Cambiano, V., Rodger, A., Lundgren, Jens, Shahmanesh, M., Gilks, C., Godfrey, C., Ehrenkranz, P., Hargreaves, J. R., Revill, P. & Cowan, F., 2022, In: AIDS. 36, 10, p. 1473-1475 3 p.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  8. Published

    HCV reinfection after HCV therapy among HIV/HCV-coinfected individuals in Europe

    Amele, S., Sandri, A. K., Rodger, A., Vandekerckhove, L., Benfield, T., Milinkovic, A., Duvivier, C., Stellbrink, H-J., Sambatakou, H., Chkhartishvili, N., Caldeira, L., Laguno, M., Domingo, P., Wandeler, G., Gisinger, M., Kuzovatova, E., Dragovic, G., Knysz, B., Matulionyte, R., Rockstroh, J. K. & 7 others, Lundgren, Jens, Mocroft, A., Peters, L., Kronborg, Gitte, Benfield, Thomas, Gerstoft, Jan & The EuroSIDA Study Group, T. E. S. G., 2022, In: HIV Medicine. 23, 6, p. 684-692 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial

    Polizzotto, M. N., Nordwall, J., Babiker, A. G., Phillips, A., Vock, D. M., Eriobu, N., Kwaghe, V., Paredes, R., Mateu, L., Ramachandruni, S., Narang, R., Jain, M. K., Lazarte, S. M., Baker, J. V., Frosch, A. E. P., Poulakou, G., Syrigos, K. N., Arnoczy, G. S., McBride, N. A., Robinson, P. A. & 31 others, Sarafian, F., Bhagani, S., Taha, H. S., Benfield, Thomas, Liu, S. T. H., Antoniadou, A., Jensen , Jens-Ulrik Stæhr , Kalomenidis, I., Susilo, A., Hariadi, P., Jensen MD, T. O., Morales-Rull, J. L., Helleberg, M., Meegada, S., Johansen, I. S., Canario, D., Fernández-Cruz, E., Metallidis, S., Shah, A., Sakurai, A., Koulouris, N. G., Trotman, R., Weintrob, A. C., Podlekareva, D., Hadi, U., Lloyd, K. M., Røge, B. T., Saito, S., Muñoz, J., Lundgren, Jens & The ITAC (INSIGHT 013) Study Group, T. I. (. 0. S. G., 2022, In: The Lancet. 399, 10324, p. 530-540 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Identifying patients with chronic lymphocytic leukemia without need of treatment: End of endless watch and wait?

    Brieghel, C., Galle, V., Agius, R., da Cunha-Bang, C., Andersen, M. A., Vlummens, P., Mattsson, M., Rosenquist, R., Smedby, K. E., Herling, C. D., Bahlo, J., Hallek, M., Lundgren, Jens, Offner, F. & Niemann, Carsten, 2022, In: European Journal of Haematology. 108, 5, p. 369-378 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Improved induced innate immune response after cART initiation in people with HIV

    Hove-Skovsgaard, M., Møller, D. L., Hald, A., Gerstoft, Jan, Lundgren, Jens, Ostrowski, Sisse Rye & Nielsen, Susanne Dam, 2022, In: Frontiers in Immunology. 13, 974767.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 Next

ID: 13961